Pfizer  logo

Pfizer PFE

$ 25.51 -0.57%

Quarterly report 2025-Q3
added 11-04-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

5.66 B

Market Cap[1]

$ 144 B

EBITDA (LTM)

$ 6.66 B

P/E (LTM)

10.45

P/S (LTM)

2.3

EPS (LTM)

2.44

Pfizer is a global pharmaceutical company that has been in operation for over 170 years. The company is headquartered in New York City and has a presence in over 150 countries worldwide. Pfizer's mission is to discover, develop, and deliver innovative medicines and vaccines that improve the lives of people around the world.

Pfizer has a diverse portfolio of products that address a range of health conditions, including cardiovascular disease, oncology, inflammation, immunology, and rare diseases. Some of the company's most well-known products include Lipitor, Viagra, and Lyrica.

In addition to developing new treatments, Pfizer is committed to improving access to healthcare for people in need. The company has established partnerships with governments, non-governmental organizations, and healthcare providers to expand access to its medicines and vaccines.

Pfizer is also dedicated to sustainability and reducing its environmental impact. The company has set ambitious goals to reduce greenhouse gas emissions, water consumption, and waste generation across its operations.

As a leading pharmaceutical company, Pfizer is constantly innovating and adapting to meet the changing needs of patients and healthcare providers. With a focus on research and development, access to healthcare, and sustainability, Pfizer is poised to continue making a positive impact on global health for years to come.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Adagene Adagene
ADAG
$ 1.9 -3.11 % $ 107 M Nasdaq Global Market chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.31 -4.06 % $ 7.96 B Nasdaq Capital Market australiaAustralia
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 25.87 -0.79 % $ 1.25 B Nasdaq Global Select Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Athira Pharma Athira Pharma
ATHA
- - $ 269 M Nasdaq Global Select Market usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 215.29 4.59 % $ 5 B Nasdaq Global Select Market danmarkDanmark
BioNTech SE BioNTech SE
BNTX
$ 105.97 -2.78 % $ 27.2 B Nasdaq Global Select Market germanyGermany
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Aytu BioScience Aytu BioScience
AYTU
$ 2.71 1.88 % $ 17 M Nasdaq Capital Market usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
$ 64.74 1.41 % $ 8.66 B Nasdaq Global Select Market,SPB usaUSA
Brickell Biotech Brickell Biotech
BBI
- -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 3.96 -1.0 % $ 8.62 B NYSE American israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Burford Capital Limited Burford Capital Limited
BUR
$ 9.63 -0.93 % $ 1.56 B NYSE britainBritain
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$ 2.97 3.12 % $ 908 M Nasdaq Capital Market israelIsrael
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Biogen Biogen
BIIB
$ 164.87 0.27 % $ 24 B Nasdaq Global Select Market,SPB usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
- - $ 100 K Nasdaq Capital Market usaUSA
BioVie BioVie
BIVI
$ 1.23 2.07 % $ 1.82 M Nasdaq Capital Market usaUSA
Baudax Bio Baudax Bio
BXRX
- 0.59 % $ 63 K Nasdaq Capital Market usaUSA
Calithera Biosciences Calithera Biosciences
CALA
- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.